http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CR-20200591-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a73cee5001ad08339ae751c10d9abf71
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate 2019-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_384ad06e927b85322b17834f7861f3ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dea50d83b26f168881a0a57590e2c01a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9f32a7c8d6006eba9ebbba433810b32
publicationDate 2021-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CR-20200591-A
titleOfInvention SALTS FROM A FGFR INHIBITOR
abstract <p> The present invention relates to salt forms of fibroblast growth factor receptor inhibitor (FGFR) 3- (2,6-difluoro-3,5-dimethoxyphenyl) -1-ethyl-8- (morpholin- 4-ylmethyl) -1,3,4,7-tetrahydro-2H-pyrrolo [3 ', 2': 5,6] pyrido [4,3-d] pyrimidin-2-one, including methods for its preparation where the compound is useful in the treatment of FGFR-mediated diseases, such as cancer. </p>
priorityDate 2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86705695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421554006

Total number of triples: 20.